Events

Clean Aviation Pitching Event
FEB
Thu
13
09:00 - 16:00

Starts in 1 month from now

Location

Brussels and online

Programmes
Climate, Energy, Mobility

The Clean Aviation partnership organizes a pitching event for their latest call on the 13 February which will take place both online and on-site. This third Call for Proposals is centred around the following areas:

  • Aircraft Concept Integration & Impact Assessment (ACI&I)
  • Ultra-efficient Short-Medium Range (SMR) aircraft architectures
  • Ultra-efficient Regional (REG) aircraft architectures

They are specifically looking for contributions to these call 3 topics.

More details on the event and how to register or prepare your pitch can be found here. 

More details on the 3rd call can be found here. 

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.